Correlation Between Pfizer and Innovator Growth

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Innovator Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Innovator Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Innovator Growth 100 Accelerated, you can compare the effects of market volatilities on Pfizer and Innovator Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Innovator Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Innovator Growth.

Diversification Opportunities for Pfizer and Innovator Growth

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and Innovator is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Innovator Growth 100 Accelerat in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator Growth 100 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Innovator Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator Growth 100 has no effect on the direction of Pfizer i.e., Pfizer and Innovator Growth go up and down completely randomly.

Pair Corralation between Pfizer and Innovator Growth

Considering the 90-day investment horizon Pfizer is expected to generate 7.02 times less return on investment than Innovator Growth. In addition to that, Pfizer is 1.41 times more volatile than Innovator Growth 100 Accelerated. It trades about 0.01 of its total potential returns per unit of risk. Innovator Growth 100 Accelerated is currently generating about 0.11 per unit of volatility. If you would invest  2,694  in Innovator Growth 100 Accelerated on August 28, 2024 and sell it today you would earn a total of  660.00  from holding Innovator Growth 100 Accelerated or generate 24.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.52%
ValuesDaily Returns

Pfizer Inc  vs.  Innovator Growth 100 Accelerat

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Innovator Growth 100 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Innovator Growth 100 Accelerated are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Innovator Growth may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pfizer and Innovator Growth Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Innovator Growth

The main advantage of trading using opposite Pfizer and Innovator Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Innovator Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator Growth will offset losses from the drop in Innovator Growth's long position.
The idea behind Pfizer Inc and Innovator Growth 100 Accelerated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals